Aurora Cannabis falls 10% as consumer revenues dive
- BySeeking Alpha-
Aurora Cannabis Inc. reported another large quarterly loss Thursday, and announced more cost-cutting, share-sale plans and executive changes as shares plunged in late trading.
Aurora Cannabis (ACB): Q3 Adjusted EBITDAloss of $24MRevenue of $55.1M (-25.1% Y/Y) misses by $13.36M.Business Transformation Plan Continues, Management Expects to Deliver...
Aurora Cannabis (ACB) was once the darling of the cannabis industry. In 2018, after having built Canada’s largest production capabilities, the company was eager to take on the...
Many observers of the cannabis sector thought that 2021 was off to a roaring start, with the shares of a number of leading companies posting double-digit gains on the prospect of...
Aurora Cannabis Inc is a Canada-based medical cannabis company. The Company’s principal strategic business lines are focused on the production, distribution and sale of cannabis in Canada and internationally. The Company is focused on offering its cannabis products to global medical cannabis market, consumer use cannabis market and global hemp-derived cannabidiol (CBD) markets. The Company offers varieties of cannabis infused products under various brands that includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and ROAR Sports. Its products portfolio includes dried cannabis, cannabis oil, soft-gels, oral dissolve strips, edibles, vaporizers and cannabis infused chocolates.